Cargando…
Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells
BACKGROUND: Gene amplification is a frequent manifestation of genomic instability that plays a role in tumour progression and development of drug resistance. It is manifested cytogenetically as extrachromosomal double minutes (DMs) or intrachromosomal homogeneously staining regions (HSRs). To better...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316941/ https://www.ncbi.nlm.nih.gov/pubmed/25537274 http://dx.doi.org/10.1136/jmedgenet-2014-102703 |
_version_ | 1782355645246210048 |
---|---|
author | Meng, Xiangning Qi, Xiuying Guo, Huanhuan Cai, Mengdi Li, Chunxiang Zhu, Jing Chen, Feng Guo, Huan Li, Jie Zhao, Yuzhen Liu, Peng Jia, Xueyuan Yu, Jingcui Zhang, Chunyu Sun, Wenjing Yu, Yang Jin, Yan Bai, Jing Wang, Mingrong Rosales, Jesusa Lee, Ki-Young Fu, Songbin |
author_facet | Meng, Xiangning Qi, Xiuying Guo, Huanhuan Cai, Mengdi Li, Chunxiang Zhu, Jing Chen, Feng Guo, Huan Li, Jie Zhao, Yuzhen Liu, Peng Jia, Xueyuan Yu, Jingcui Zhang, Chunyu Sun, Wenjing Yu, Yang Jin, Yan Bai, Jing Wang, Mingrong Rosales, Jesusa Lee, Ki-Young Fu, Songbin |
author_sort | Meng, Xiangning |
collection | PubMed |
description | BACKGROUND: Gene amplification is a frequent manifestation of genomic instability that plays a role in tumour progression and development of drug resistance. It is manifested cytogenetically as extrachromosomal double minutes (DMs) or intrachromosomal homogeneously staining regions (HSRs). To better understand the molecular mechanism by which HSRs and DMs are formed and how they relate to the development of methotrexate (MTX) resistance, we used two model systems of MTX-resistant HT-29 colon cancer cell lines harbouring amplified DHFR primarily in (i) HSRs and (ii) DMs. RESULTS: In DM-containing cells, we found increased expression of non-homologous end joining (NHEJ) proteins. Depletion or inhibition of DNA-PKcs, a key NHEJ protein, caused decreased DHFR amplification, disappearance of DMs, increased formation of micronuclei or nuclear buds, which correlated with the elimination of DHFR, and increased sensitivity to MTX. These findings indicate for the first time that NHEJ plays a specific role in DM formation, and that increased MTX sensitivity of DM-containing cells depleted of DNA-PKcs results from DHFR elimination. Conversely, in HSR-containing cells, we found no significant change in the expression of NHEJ proteins. Depletion of DNA-PKcs had no effect on DHFR amplification and resulted in only a modest increase in sensitivity to MTX. Interestingly, both DM-containing and HSR-containing cells exhibited decreased proliferation upon DNA-PKcs depletion. CONCLUSIONS: We demonstrate a novel specific role for NHEJ in the formation of DMs, but not HSRs, in MTX-resistant cells, and that NHEJ may be targeted for the treatment of MTX-resistant colon cancer. |
format | Online Article Text |
id | pubmed-4316941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-43169412015-02-11 Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells Meng, Xiangning Qi, Xiuying Guo, Huanhuan Cai, Mengdi Li, Chunxiang Zhu, Jing Chen, Feng Guo, Huan Li, Jie Zhao, Yuzhen Liu, Peng Jia, Xueyuan Yu, Jingcui Zhang, Chunyu Sun, Wenjing Yu, Yang Jin, Yan Bai, Jing Wang, Mingrong Rosales, Jesusa Lee, Ki-Young Fu, Songbin J Med Genet Cancer Genetics BACKGROUND: Gene amplification is a frequent manifestation of genomic instability that plays a role in tumour progression and development of drug resistance. It is manifested cytogenetically as extrachromosomal double minutes (DMs) or intrachromosomal homogeneously staining regions (HSRs). To better understand the molecular mechanism by which HSRs and DMs are formed and how they relate to the development of methotrexate (MTX) resistance, we used two model systems of MTX-resistant HT-29 colon cancer cell lines harbouring amplified DHFR primarily in (i) HSRs and (ii) DMs. RESULTS: In DM-containing cells, we found increased expression of non-homologous end joining (NHEJ) proteins. Depletion or inhibition of DNA-PKcs, a key NHEJ protein, caused decreased DHFR amplification, disappearance of DMs, increased formation of micronuclei or nuclear buds, which correlated with the elimination of DHFR, and increased sensitivity to MTX. These findings indicate for the first time that NHEJ plays a specific role in DM formation, and that increased MTX sensitivity of DM-containing cells depleted of DNA-PKcs results from DHFR elimination. Conversely, in HSR-containing cells, we found no significant change in the expression of NHEJ proteins. Depletion of DNA-PKcs had no effect on DHFR amplification and resulted in only a modest increase in sensitivity to MTX. Interestingly, both DM-containing and HSR-containing cells exhibited decreased proliferation upon DNA-PKcs depletion. CONCLUSIONS: We demonstrate a novel specific role for NHEJ in the formation of DMs, but not HSRs, in MTX-resistant cells, and that NHEJ may be targeted for the treatment of MTX-resistant colon cancer. BMJ Publishing Group 2015-02 2014-12-23 /pmc/articles/PMC4316941/ /pubmed/25537274 http://dx.doi.org/10.1136/jmedgenet-2014-102703 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Cancer Genetics Meng, Xiangning Qi, Xiuying Guo, Huanhuan Cai, Mengdi Li, Chunxiang Zhu, Jing Chen, Feng Guo, Huan Li, Jie Zhao, Yuzhen Liu, Peng Jia, Xueyuan Yu, Jingcui Zhang, Chunyu Sun, Wenjing Yu, Yang Jin, Yan Bai, Jing Wang, Mingrong Rosales, Jesusa Lee, Ki-Young Fu, Songbin Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells |
title | Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells |
title_full | Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells |
title_fullStr | Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells |
title_full_unstemmed | Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells |
title_short | Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells |
title_sort | novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells |
topic | Cancer Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316941/ https://www.ncbi.nlm.nih.gov/pubmed/25537274 http://dx.doi.org/10.1136/jmedgenet-2014-102703 |
work_keys_str_mv | AT mengxiangning novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT qixiuying novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT guohuanhuan novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT caimengdi novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT lichunxiang novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT zhujing novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT chenfeng novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT guohuan novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT lijie novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT zhaoyuzhen novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT liupeng novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT jiaxueyuan novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT yujingcui novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT zhangchunyu novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT sunwenjing novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT yuyang novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT jinyan novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT baijing novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT wangmingrong novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT rosalesjesusa novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT leekiyoung novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells AT fusongbin novelrolefornonhomologousendjoiningintheformationofdoubleminutesinmethotrexateresistantcoloncancercells |